Benzinga - by Benzinga Insights, Benzinga Staff Writer. Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 4.31% on an annualized basis producing an...
Benzinga - by Benzinga Insights, Benzinga Staff Writer. Cardinal Health's (NYSE:CAH) short percent of float has risen 18.45% since its last report. The company recently reported...
Friday, the FDA said that Becton, Dickinson, And Company (NYSE: BDX) is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health Inc's (NYSE: CAH)...
Benzinga - by Lisa Levin, Benzinga Editor. On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would not buy CRISPR Therapeutics AG (NASDAQ: CRSP) stock "all the way...
The FDA warns people should stop using more than two dozen eye-drop products that pose a risk of infection, which could cause partial vision loss or blindness.
Benzinga - by Lisa Levin, Benzinga Editor. U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in...
Investing.com - Cardinal Health (NYSE: CAH) reported first quarter EPS of $1.73, $0.32 better than the analyst estimate of $1.41. Revenue for the quarter came in at $54.8B versus...
Cardinal Health (CAH) declared a quarterly dividend of $0.5006 per share, or $2.0024 annualized. The dividend will be payable on January 15, 2024, to stockholders of record on...